Tenderwize
Back to tender search

Open-house rebate agreements for Nitrendipin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 222 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive supply/rebate agreements for pharmaceutical products containing Nitrendipin (ATC C08CA08).
  • Open-house model with uniform terms for all participating pharmaceutical companies.
Show full summary

This is an open-house pharmaceutical supply notice for non-exclusive rebate agreements on the active substance Nitrendipin (ATC C08CA08) for AOK Rheinland-Pfalz/Saarland. The model is not a standard competitive public procurement, but the notice still sets formal submission and eligibility conditions. Contracts can start from 01.06.2025 and run for up to 24 months, with monthly entry possible during the term. No contract value is stated. Procurement documents are available via a URL, but no extracted contract document text was provided, so they were not analyzed.

Risks

The first participation date required receipt of documents by 30.04.2025, while later entry depends on monthly cut-offs...

Submission must be in original form and electronic submission is not allowed.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorized and marketable medicines in Germany may be supplied under the contract.

Administrative

  • If the product is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided.
  • The AMIce extract must show name, MA holder or other marketing authorization basis, dosage form, active substance, and marketability.

Buyer

Lots (1)

LOT-0001

Open-house rebate agreements for Nitrendipin

Single lot covering non-exclusive open-house rebate agreements for medicines containing the active substance Nitrendipin (ATC C08CA08). The scope excludes children’s medicines on the BfArM list under §35(5a) SGB V. The buyer states that terms are uniform for all participants, with no individual negotiations. Information in this lot comes from the structured data and XML notice.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
236770-2025

Documents (1)

Similar tenders